Bridging the gaps in cancer care for Hispanics: Striving for equity and fairness in scientific advancements

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Our Hispanic community is a vibrant and essential part of the American tapestry, contributing richly to the country’s society, culture, and economy. Yet, when it comes to healthcare, this community grapples with significant disparities, especially in cancer care. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Mecker G. Möller, MD
Surgical oncologist, Professor of surgery, University of Chicago Medicine Comprehensive Cancer Center
Table of Contents

YOU MAY BE INTERESTED IN

At a lecture at Yale Cancer Center recently, Robert A. Winn brandished a copy of a 32-year old booklet titled “Cancer at a Crossroads: A Report to Congress for the Nation,” using it as a show-and-tell prop in arguing that America’s cancer program is once again at a crossroads and therefore in urgent need of strategic thinking (The Cancer Letter, April 10, 2026).
The California Institute for Regenerative Medicine, a state agency tasked with awarding billions of dollars of scientific funding for stem cell and gene therapy, has rescinded a controversial policy that was disrupting the flow of funding to cancer research.
Mecker G. Möller, MD
Surgical oncologist, Professor of surgery, University of Chicago Medicine Comprehensive Cancer Center

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login